Haemonetics Corporation (HAE)
NYSE: HAE · Real-Time Price · USD
57.32
-1.10 (-1.88%)
At close: Apr 10, 2026, 4:00 PM EDT
57.30
-0.02 (-0.03%)
After-hours: Apr 10, 2026, 7:00 PM EDT
Haemonetics Market Cap
Haemonetics has a market cap or net worth of $2.66 billion as of April 10, 2026. Its market cap has decreased by -17.48% in one year.
Market Cap
2.66B
Enterprise Value
3.53B
1-Year Change
-17.48%
Ranking
Category
Stock Price
$57.32
Market Cap Chart
Since December 1, 1998, Haemonetics's market cap has increased from $605.00M to $2.66B, an increase of 340.29%. That is a compound annual growth rate of 5.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 2.66B | -29.00% |
| Dec 31, 2025 | 3.75B | -4.33% |
| Dec 31, 2024 | 3.92B | -9.62% |
| Dec 29, 2023 | 4.34B | 9.01% |
| Dec 30, 2022 | 3.98B | 46.84% |
| Dec 31, 2021 | 2.71B | -55.05% |
| Dec 31, 2020 | 6.03B | 3.54% |
| Dec 31, 2019 | 5.82B | 12.62% |
| Dec 31, 2018 | 5.17B | 68.56% |
| Dec 29, 2017 | 3.07B | 47.73% |
| Dec 30, 2016 | 2.08B | 26.98% |
| Dec 31, 2015 | 1.64B | -14.87% |
| Dec 31, 2014 | 1.92B | -11.51% |
| Dec 31, 2013 | 2.17B | 3.06% |
| Dec 31, 2012 | 2.11B | 37.73% |
| Dec 30, 2011 | 1.53B | -2.18% |
| Dec 31, 2010 | 1.56B | 10.69% |
| Dec 31, 2009 | 1.41B | -1.15% |
| Dec 31, 2008 | 1.43B | -10.77% |
| Dec 31, 2007 | 1.60B | 32.14% |
| Dec 29, 2006 | 1.21B | -6.31% |
| Dec 30, 2005 | 1.29B | 40.58% |
| Dec 31, 2004 | 920.10M | 59.08% |
| Dec 31, 2003 | 578.40M | 10.51% |
| Dec 31, 2002 | 523.40M | -41.55% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TransMedics Group | 3.91B |
| iRhythm Holdings | 3.72B |
| LivaNova | 3.43B |
| Integer Holdings | 2.90B |
| Neogen | 2.05B |
| Artivion | 1.82B |
| Establishment Labs Holdings | 1.76B |
| Axogen | 1.66B |